Bray Capital Advisors Soleno Therapeutics Inc Transaction History

Bray Capital Advisors

  • $381 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$0.14 - $0.23 $280 - $460
-2,000 Closed
0 $0
Q3 2021

Oct 28, 2021
BUY
$0.8 - $1.12 $1,600 - $2,240
2,000 New
2,000 $2,000

Others Institutions Holding SLNO

# of Institutions
1
Shares Held
550K
Call Options Held
0
Put Options Held
0
View Full List

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $331M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Bray Capital Advisors Portfolio

Follow Bray Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bray Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bray Capital Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email